Through innovative pharmaceutical technology, China's first traditional Chinese medicine new drug created using AI was transformed and implemented in just 2 years, achieving large-scale high-quality production and shortening the time by half compared to traditional methods. With the iteration and upgrading of AI pharmaceutical technology, the speed of new drug production and market launch will be greatly accelerated. ”At the 10th Smart Pharmaceutical Academic Industry Conference, Cheng Yiyu, an executive member of the National Pharmacopoeia Commission and a distinguished professor at Zhejiang University, told reporters that the new generation of artificial intelligence and robots is restructuring the technology landscape of new drug research and development. At the conference hosted by the National Key Laboratory of Modern Chinese Medicine Creation, more than 300 representatives from industry, academia, and research sectors deeply discussed the path of digital transformation and development in the pharmaceutical industry, from theoretical innovation to technological breakthroughs in smart pharmaceuticals. In the past decade, China's pharmaceutical industry has achieved a historic leap from mechanization and automation to digitalization and networking, and accelerated towards intelligence. ”Zhang Boli, director of the National Key Laboratory of Modern Chinese Medicine Creation, said that the "Hangzhou Declaration of China Smart Pharmaceutical 2025" has opened a new journey for the digital transformation and upgrading of China's pharmaceutical industry. In the past decade, China's smart pharmaceuticals have transformed from concept implementation to productivity. ”Cheng Yiyu introduced that in the past decade, the Chinese Medicine Pharmaceutical Engineering Branch of the Chinese Association of Traditional Chinese Medicine has been established, and four group standards including the "General Principles for Intelligent Manufacturing Technology of Traditional Chinese Medicine" have been formulated and released. 23 pharmaceutical companies, 9 pharmaceutical universities, and 11 comprehensive university pharmaceutical related departments have jointly established the "Innovative Development Community of New Quality Productivity in the Pharmaceutical Industry", accelerating the development of new quality productivity in the pharmaceutical industry. In the past decade, a large number of intelligent drug manufacturing production lines, intelligent pharmaceutical factories or workshops have been built, promoting numerous pharmaceutical companies to enter the ranks of provincial-level intelligent factories. Benchmark enterprises have also been selected as national excellent intelligent factories and national green factories, achieving fruitful results in the theory and practice of intelligent pharmaceutical engineering. ”Cheng Yiyu said. The deep integration of AI and pharmaceutical engineering empowers the development of the pharmaceutical industry. Zhang Boli pointed out that more than 20 years ago, experts and scholars such as Cheng Yiyu proposed the core concept of "deeply integrating modern information technology into the entire process of traditional Chinese medicine pharmaceuticals" with the vision of interdisciplinary integration, and promoted the construction of a collaborative innovation system between industry, academia, and research, leading the industry to embark on a journey of exploration and practice. In the face of a new round of technological revolution and industrial transformation, Zhang Boli proposed four thoughts on the deep integration of AI and the pharmaceutical industry: firstly, in the face of the trend of AI empowering the pharmaceutical industry, we should actively take action and be down-to-earth; Secondly, for the digital transformation and intelligent transformation of pharmaceutical enterprises, it is necessary to actively promote and tailor the work accordingly; The third is to build a digital technology system for the pharmaceutical industry, which requires both breakthroughs and collaborative sharing; The fourth is the digital transformation of the pharmaceutical industry, which requires both innovation driven and value boosting for enterprises. As an important support for the Healthy China strategy, the high-quality development of the pharmaceutical industry has attracted much attention. In April of this year, seven departments including the Ministry of Industry and Information Technology issued the "Implementation Plan for the Digital Transformation of the Pharmaceutical Industry (2025-2030)", which pointed out the development direction for the industry. Cheng Yiyu proposed that in the next decade, the pharmaceutical engineering industry should work together to study how to use AI robot technology to promote industry quality and efficiency improvement, cost control and consumption reduction, energy conservation and emission reduction, and promote China's transition from a "pharmaceutical power" to a "pharmaceutical powerhouse". (New Society)